Opinion|Videos|March 21, 2025

Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations

Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.

Video content above is prompted by the following:

What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo